BRCA1 is a histone-H2A-specific ubiquitin ligase

Cell Reports

Volumn 8, Issue 4, 2014, Pages 999-1005

  Kalb, Reinhard ^a,b   Mallery, Donna L ^a   Larkin, Conor ^c   Huang, Jeffrey T J ^c   Hiom, Kevin ^a,c  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; BRCA1 PROTEIN; HISTONE H2A; UBIQUITIN PROTEIN LIGASE; BARD1 PROTEIN, HUMAN; BRCA1 PROTEIN, HUMAN; HISTONE; NUCLEOSOME; TUMOR SUPPRESSOR PROTEIN; LYSINE;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA DAMAGE; ENZYME SPECIFICITY; HISTONE UBIQUITINATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; AMINO ACID SEQUENCE; ANIMAL; CHICKEN; ENZYME ACTIVE SITE; HEK293 CELL LINE; HELA CELL LINE; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; UBIQUITINATION; XENOPUS LAEVIS; CHROMATIN; CONTROLLED STUDY; PROTEIN LOCALIZATION; RING FINGER MOTIF;

AMINO ACID SEQUENCE; ANIMALS; BRCA1 PROTEIN; CATALYTIC DOMAIN; CHICKENS; HEK293 CELLS; HELA CELLS; HISTONES; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEOSOMES; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION; XENOPUS LAEVIS;

EID: 84908356633     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.07.025     Document Type: Article

References (30)

1. Bentley M.L., Corn J.E., Dong K.C., Phung Q., Cheung T.K., Cochran A.G. Recognition of UbcH5c and the nucleosome by the Bmi1/Ring1b ubiquitin ligase complex. EMBO J. 2011, 30:3285-3297.
2. Brzovic P.S., Rajagopal P., Hoyt D.W., King M.C., Klevit R.E. Structure of a BRCA1-BARD1 heterodimeric RING-RING complex. Nat. Struct. Biol. 2001, 8:833-837.
3. Brzovic P.S., Lissounov A., Christensen D.E., Hoyt D.W., Klevit R.E. A UbcH5/ubiquitin noncovalent complex is required for processive BRCA1-directed ubiquitination. Mol. Cell 2006, 21:873-880.
4. Buchwald G., van der Stoop P., Weichenrieder O., Perrakis A., van Lohuizen M., Sixma T.K. Structure and E3-ligase activity of the Ring-Ring complex of polycomb proteins Bmi1 and Ring1b. EMBO J. 2006, 25:2465-2474.
5. Campbell S.J., Edwards R.A., Leung C.C., Neculai D., Hodge C.D., Dhe-Paganon S., Glover J.N. Molecular insights into the function of RING finger (RNF)-containing proteins hRNF8 and hRNF168 in Ubc13/Mms2-dependent ubiquitylation. J.Biol. Chem. 2012, 287:23900-23910.
6. *BARD1 RING ubiquitin ligase. J.Biol. Chem. 2002, 277:22085-22092.
7. Christensen D.E., Brzovic P.S., Klevit R.E. E2-BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages. Nat. Struct. Mol. Biol. 2007, 14:941-948.
8. Coleman K.A., Greenberg R.A. The BRCA1-RAP80 complex regulates DNA repair mechanism utilization by restricting end resection. J.Biol. Chem. 2011, 286:13669-13680.
9. Doil C., Mailand N., Bekker-Jensen S., Menard P., Larsen D.H., Pepperkok R., Ellenberg J., Panier S., Durocher D., Bartek J., et al. RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins. Cell 2009, 136:435-446.
10. Elderkin S., Maertens G.N., Endoh M., Mallery D.L., Morrice N., Koseki H., Peters G., Brockdorff N., Hiom K. A phosphorylated form of Mel-18 targets the Ring1B histone H2A ubiquitin ligase to chromatin. Mol. Cell 2007, 28:107-120.
11. Gospodinov A., Herceg Z. Shaping chromatin for repair. Mutat. Res. 2013, 752:45-60.
12. Hashizume R., Fukuda M., Maeda I., Nishikawa H., Oyake D., Yabuki Y., Ogata H., Ohta T. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J.Biol. Chem. 2001, 276:14537-14540.
13. Leung J.W., Agarwal P., Canny M.D., Gong F., Robison A.D., Finkelstein I.J., Durocher D., Miller K.M. Nucleosome acidic patch promotes RNF168- and RING1B/BMI1-dependent H2AX and H2A ubiquitination and DNA damage signaling. PLoS Genet. 2014, 10:e1004178.
14. Li Z., Cao R., Wang M., Myers M.P., Zhang Y., Xu R.M. Structure of a Bmi-1-Ring1B polycomb group ubiquitin ligase complex. J.Biol. Chem. 2006, 281:20643-20649.
15. Mallery D.L., Vandenberg C.J., Hiom K. Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains. EMBO J. 2002, 21:6755-6762.
16. Mattiroli F., Vissers J.H., van Dijk W.J., Ikpa P., Citterio E., Vermeulen W., Marteijn J.A., Sixma T.K. RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA damage signaling. Cell 2012, 150:1182-1195.
17. Mattiroli F., Uckelmann M., Sahtoe D.D., van Dijk W.J., Sixma T.K. The nucleosome acidic patch plays a critical role in RNF168-dependent ubiquitination of histone H2A. Nat. Commun. 2014, 5:3291.
18. Morris J.R., Solomon E. BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair. Hum. Mol. Genet. 2004, 13:807-817.
19. Moynahan M.E., Jasin M. Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis. Nat. Rev. Mol. Cell Biol. 2010, 11:196-207.
20. Paull T.T., Cortez D., Bowers B., Elledge S.J., Gellert M. Direct DNA binding by Brca1. Proc. Natl. Acad. Sci. USA 2001, 98:6086-6091.
21. Reid L.J., Shakya R., Modi A.P., Lokshin M., Cheng J.T., Jasin M., Baer R., Ludwig T. E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks. Proc. Natl. Acad. Sci. USA 2008, 105:20876-20881.
22. Ruffner H., Joazeiro C.A., Hemmati D., Hunter T., Verma I.M. Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity. Proc. Natl. Acad. Sci. USA 2001, 98:5134-5139.
23. Shakya R., Reid L.J., Reczek C.R., Cole F., Egli D., Lin C.S., deRooij D.G., Hirsch S., Ravi K., Hicks J.B., et al. BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity. Science 2011, 334:525-528.
24. Stewart G.S., Panier S., Townsend K., Al-Hakim A.K., Kolas N.K., Miller E.S., Nakada S., Ylanko J., Olivarius S., Mendez M., et al. The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage. Cell 2009, 136:420-434.
25. Thomas J.O., Butler P.J. Size-dependence of a stable higher-order structure of chromatin. J.Mol. Biol. 1980, 144:89-93.
26. Venkitaraman A.R. Functions of BRCA1 and BRCA2 in the biological response to DNA damage. J.Cell Sci. 2001, 114:3591-3598.
27. Wang H., Wang L., Erdjument-Bromage H., Vidal M., Tempst P., Jones R.S., Zhang Y. Role of histone H2A ubiquitination in Polycomb silencing. Nature 2004, 431:873-878.
28. Wu L.C., Wang Z.W., Tsan J.T., Spillman M.A., Phung A., Xu X.L., Yang M.C., Hwang L.Y., Bowcock A.M., Baer R. Identification of a RING protein that can interact invivo with the BRCA1 gene product. Nat. Genet. 1996, 14:430-440.
29. Xu B., Kim St, Kastan M.B. Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol. Cell. Biol. 2001, 21:3445-3450.
30. Zhu Q., Pao G.M., Huynh A.M., Suh H., Tonnu N., Nederlof P.M., Gage F.H., Verma I.M. BRCA1 tumour suppression occurs via heterochromatin-mediated silencing. Nature 2011, 477:179-184.